Connect your AI

Limoneira LMNR Noncash lease expense

Noncash lease expense at other companies

Candel Therapeutics, Inc.CADL

$92K+24.3%

Rush Street InteractiveRSI

$265K+18.3%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$50K-62.4%

HRO

HarrowHROW

$192K-11.5%

MapLight Therapeutics, Inc. MPLT

$229K+8.0%

UiPathPATH

$3.02M-28.0%

Other financials

Income statement

Revenue$23.9M-31.9%

Gross profit$768.0K-77.5%

Operating income-$21.7M-549%

Net income-$21.4M-537%

EPS (diluted)-$1.20-500%

Balance sheet

Cash & equivalents$891.0K-57.2%

Total debt$99.2M+72.0%

Total equity$152.9M-16.3%

Total assets$293.8M-0.9%

Cash flow

Operating cash flow-$4.5M—

CapEx$880.0K+95.1%

Free cash flow-$4.3M—

Valuation

Market cap$238.07M-17.7%

Enterprise value$336.42M-2.5%

P/S1.8×+0.2×

Profitability

Gross margin8.5%—

Operating margin-33.2%-34.7pp

Net margin-30.5%—

FCF margin7.8%—

Returns & leverage

Return on equity-24.1%—

Debt / equity0.6×+0.3×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Limoneira in its filing.

Tagged under the XBRL concept us-gaap:NoncashContributionExpense.

The official record: Limoneira’s 10-Q, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Limoneira's noncash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Limoneira's noncash lease expense?: Limoneira (LMNR) reported noncash lease expense of $731K in Q4 2025.
How has Limoneira's noncash lease expense changed year-over-year?: Limoneira's noncash lease expense increased by 162.0% year-over-year, from $279K to $731K.